The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

Colon cancer (colorectal cancer) remains one of the most common and deadly cancers. It is now the leading cause of cancer deaths in Americans under age 50, and the second leading cause of cancer ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

As of July 1, Ontario will offer publicly funded colorectal cancer (CRC) screening to patients as young as 45 years. Patients ...

Starting next month, Ontarians who are 45 years old will be eligible for colorectal cancer screening. Some patients and ...

Give dad the gift of more time this Father's Day. 10 evidence-based healthy habits and screening tests that can add over a ...